News

stents biforcation clinical trial study cath lab tryton tct side branch

Tryton Medical Inc., a developer of stents designed to treat bifurcation lesions, announced activities...

xience prime xpedition V antiplatelet stents eluting clinical trial study cath

Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate the use...

stents bioresorbable fortitude amaranth

Amaranth Medical, a privately held medical device company, presented positive six-month angiographic results from its first-in-human study including patients undergoing percutaneous...

balloon catheters stents clinical trial study orbusneich scoreflex journal

OrbusNeich announced the publication of a study demonstrating that lesion preparation with the company’s...

biotronik orsiro stents drug-eluting cinical trial bioflow

Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to verify the efficacy...

stents drug eluting biosensors tct 2012 transcatheter biomatrix neoflex spectrum

Biosensors International’s expanded product portfolio offers physicians a broader range of treatment options to improve patient outcomes.

October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

stents peripheral artery disease pad devices fda lifestent solo vascular bard

Bard Peripheral Vascular has sent an urgent Class I medical device recall notification letter informing customers of the problems of the LifeStent Solo ...

stents peripheral atherectomy devices artery disease PAD covidien everflex

Covidien released positive final results from its Durability II study and promising preliminary data from its Definitive AR trial at the Vascular Interventional Advances (VIVA) 2013 conference in...

boston scientific stents peripheral clinical trial study innova des drug-eluting

Launching a clinical trial expected to serve as the foundation for global regulatory approvals, a physician in...

cath lab stents ostial accessclosure flash system dual balloon angioplasty

AccessClosure Inc. announced an exclusive agreement with Ostial Corp. to distribute the Flash Ostial System Dual Balloon Angioplasty ...

Micell Technologies Inc. announced that a peer reviewed article discussing imaging and clinical results of the...

stents peripheral peripheral artery disease pad clinical trial study bioflex

Biotronik announced it has completed patient enrollment in the iliac arm of its Bioflex-I trial. Under the supervision of Mark Burket, M.D. and chief, Cardiovascular Division at the University of...

Emergency surgery and advanced cardiac disease are risk factors for major adverse cardiac events (MACE) after noncardiac surgery in patients with recent coronary stent ...

Physicians at the Heart Hospital of Austin, enrolled and successfully treated the first patient in the Roadster study, a global, multicenter ...

stents cath lab FDA update guidance delivery system

The U.S. Food and Drug Administration (FDA) released a draft of its proposed updates for the non-clinical engineering tests and recommended labeling for intravascular ...

stent peripheral artery disease treatment complete se medtronic

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and performance in routine clinical practice. The...